{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:13:57Z","timestamp":1724112837218},"reference-count":40,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,19]]},"DOI":"10.7759\/cureus.67175","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T08:55:28Z","timestamp":1724057728000},"source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis C Virus Seroprevalence and Genotypic Distribution Among Hemodialysis Patients at a Teaching and Training Hospital in Western Rajasthan, India"],"prefix":"10.7759","author":[{"given":"Shivani","family":"Khullar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varun","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabhat K","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tejaswee","family":"Lohakare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"World Health Organization. Hepatitis C. (2024). Accessed: August 18, 2024: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/sdi.12761","article-title":"Transmission of hepatitis C virus in the dialysis setting and strategies for its prevention","volume":"32","author":"Nguyen DB","year":"2019","unstructured":"Nguyen DB, Bixler D, Patel PR. Transmission of hepatitis C virus in the dialysis setting and strategies for its prevention. Semin Dial. 2019, 32:127-34. 10.1111\/sdi.12761","journal-title":"Semin Dial"},{"key":"ref3","article-title":"Hepatitis C virus (HCV) infection in hemodialysis patients in the south of Jordan","volume":"20","author":"Al-Jamal M","year":"2009","unstructured":"Al-Jamal M, Al-Qudah A, Al-Shishi KF, Al-Sarayreh A, Al-Quraan L. Hepatitis C virus (HCV) infection in hemodialysis patients in the south of Jordan. Saudi J Kidney Dis Transpl. 2009, 20:488-92.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.18502\/ijm.v12i6.5041","article-title":"Prevalence of hepatitis C among haemodialysis patients in a tertiary care hospital in South India","volume":"12","author":"Madhavan A","year":"2020","unstructured":"Madhavan A, Sachu A, Balakrishnan AK, Vasudevan A, Balakrishnan S, Vasudevapanicker J. Prevalence of hepatitis C among haemodialysis patients in a tertiary care hospital in South India. Iran J Microbiol. 2020, 12:644-9. 10.18502\/ijm.v12i6.5041","journal-title":"Iran J Microbiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_1017_21","article-title":"Prevalence of hepatitis B and hepatitis C in patients undergoing hemodialysis at a teaching hospital in Uttarakhand","volume":"11","author":"Raina D","year":"2022","unstructured":"Raina D, Rawat N, Pandita AK. Prevalence of hepatitis B and hepatitis C in patients undergoing hemodialysis at a teaching hospital in Uttarakhand. J Family Med Prim Care. 2022, 11:1348-53. 10.4103\/jfmpc.jfmpc_1017_21","journal-title":"J Family Med Prim Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00649.x","article-title":"Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS","volume":"65","author":"Fissell RB","year":"2004","unstructured":"Fissell RB, Bragg-Gresham JL, Woods JD, et al.. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2004, 65:2335-42. 10.1111\/j.1523-1755.2004.00649.x","journal-title":"Kidney Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000355615","article-title":"Hepatitis C infection is very rarely treated among hemodialysis patients","volume":"38","author":"Goodkin DA","year":"2013","unstructured":"Goodkin DA, Bieber B, Gillespie B, Robinson BM, Jadoul M. Hepatitis C infection is very rarely treated among hemodialysis patients. Am J Nephrol. 2013, 38:405-12. 10.1159\/000355615","journal-title":"Am J Nephrol"},{"key":"ref8","article-title":"Detection of hepatitis C virus infection and its genotypic characterization among hemodialysis patients by HCV core antigen ELISA and RTPCR- a hospital-based prospective study in a tertiary care hospital in South India","volume":"5","author":"Rani VS","year":"2023","unstructured":"Rani VS, Pavani S, Reddy PS, Srinath M. Detection of hepatitis C virus infection and its genotypic characterization among hemodialysis patients by HCV core antigen ELISA and RTPCR- a hospital-based prospective study in a tertiary care hospital in South India. Int J Acad Med Pharm. 2023, 5:628-32.","journal-title":"Int J Acad Med Pharm"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27259","article-title":"Global distribution and prevalence of hepatitis C virus genotypes","volume":"61","author":"Messina JP","year":"2015","unstructured":"Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, Barnes E. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015, 61:77-87. 10.1002\/hep.27259","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.17226\/24731","article-title":"A national strategy for the elimination of hepatitis B and C: Phase two report","author":"National Academies of Sciences","year":"2017","unstructured":"National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, Committee on a National Strategy for the Elimination of Hepatitis B and C. A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report. Strom BL, Buckley GJ (ed): National Academies Press, Washington, DC; 2017. 10.17226\/24731"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.1895","article-title":"Impact of HCV genotype on treatment regimens and drug resistance: a snapshot in time","volume":"26","author":"Cuypers L","year":"2016","unstructured":"Cuypers L, Ceccherini-Silberstein F, Van Laethem K, Li G, Vandamme AM, Rockstroh JK. Impact of HCV genotype on treatment regimens and drug resistance: a snapshot in time. Rev Med Virol. 2016, 26:408-34. 10.1002\/rmv.1895","journal-title":"Rev Med Virol"},{"key":"ref12","article-title":"Testing for HCV infection: an update of guidance for clinicians and laboratorians","volume":"62","author":"Getchell JP","year":"2013","unstructured":"Getchell JP, Wroblewski KE, DeMaria A Jr, et al.. Testing for HCV infection: an update of guidance for clinicians and laboratorians. MMWR Morb Mortal Wkly Rep. 2013, 62:362-5.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1996.tb01313.x","article-title":"Collaborative study to assess the suitability of an HCV RNA reference sample for detection of an HCV RNA in plasma pools by PCR","volume":"70","author":"Saldanha J","year":"1996","unstructured":"Saldanha J, Minor P. Collaborative study to assess the suitability of an HCV RNA reference sample for detection of an HCV RNA in plasma pools by PCR. Vox Sang. 1996, 70:148-51. 10.1111\/j.1423-0410.1996.tb01313.x","journal-title":"Vox Sang"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2018.08.001","article-title":"Prevalence and genotyping pattern of hepatitis C virus among patients on maintenance hemodialysis at five centers in Pune, India","volume":"75","author":"Roy P","year":"2019","unstructured":"Roy P, Patel A, Lole K, Gupta RM, Kumar A, Hazra S. Prevalence and genotyping pattern of hepatitis C virus among patients on maintenance hemodialysis at five centers in Pune, India. Med J Armed Forces India. 2019, 75:74-80. 10.1016\/j.mjafi.2018.08.001","journal-title":"Med J Armed Forces India"},{"key":"ref15","article-title":"Hepatitis B, hepatitis C, and human immune deficiency virus seroconversion positivity rates and their potential risk factors among patients on maintenance hemodialysis in Cameroon","volume":"10","author":"Halle MP","year":"2016","unstructured":"Halle MP, Choukem SP, Kaze FF, et al.. Hepatitis B, hepatitis C, and human immune deficiency virus seroconversion positivity rates and their potential risk factors among patients on maintenance hemodialysis in Cameroon. Iran J Kidney Dis. 2016, 10:304-9.","journal-title":"Iran J Kidney Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s43162-020-00005-0","article-title":"Prevalence and seroconversion of hepatitis C among hemodialysis patients in Assiut governorate, Egypt","volume":"32","author":"Kerollos KM","year":"2020","unstructured":"Kerollos KM, El-Ameen HA, Abd El Wahed L, Azoz NM. Prevalence and seroconversion of hepatitis C among hemodialysis patients in Assiut governorate, Egypt. Egypt J Intern Med. 2020, 32:1-6. 10.1186\/s43162-020-00005-0","journal-title":"Egypt J Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2019.11.002","article-title":"Incidence and risk factors for hepatitis C virus and hepatitis B virus seroconversion in end-stage renal failure patients on maintenance hemodialysis","volume":"10","author":"Kataruka M","year":"2020","unstructured":"Kataruka M, Gupta S, Ramchandran R, Singh M, Dhiman RK, Lal Gupta K. Incidence and risk factors for hepatitis C virus and hepatitis B virus seroconversion in end-stage renal failure patients on maintenance hemodialysis. J Clin Exp Hepatol. 2020, 10:316-21. 10.1016\/j.jceh.2019.11.002","journal-title":"J Clin Exp Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2019.160","article-title":"Sero conversion of viral hepatitis among end stage renal disease patients on hemodialysis in Kashmir: results of a prospective study","volume":"7","author":"Masoodi I","year":"2019","unstructured":"Masoodi I, Singh C, Wani IA, Wani MM, Ahmed TI, Sheikh RY. Sero conversion of viral hepatitis among end stage renal disease patients on hemodialysis in Kashmir: results of a prospective study. Open Access Maced J Med Sci. 2019, 7:587-93. 10.3889\/oamjms.2019.160","journal-title":"Open Access Maced J Med Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2019.09.012","article-title":"Prevalence of hypertension among 388 Indian adults: results from the great India blood pressure survey","volume":"71","author":"Ramakrishnan S","year":"2019","unstructured":"Ramakrishnan S, Zachariah G, Gupta K, et al.. Prevalence of hypertension among 388 Indian adults: results from the great India blood pressure survey. Indian Heart J. 2019, 71:309-13. 10.1016\/j.ihj.2019.09.012","journal-title":"Indian Heart J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2018.202","article-title":"Hepatitis C virus infection in chronic kidney disease: paradigm shift in management","volume":"33","author":"Kim SM","year":"2018","unstructured":"Kim SM, Song IH. Hepatitis C virus infection in chronic kidney disease: paradigm shift in management. Korean J Intern Med. 2018, 33:670-8. 10.3904\/kjim.2018.202","journal-title":"Korean J Intern Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2021.05.011","article-title":"Laboratory evaluation of hepatitis C virus infection in patients undergoing hemodialysis from North East India","volume":"12","author":"Kalita D","year":"2022","unstructured":"Kalita D, Deka S, Chamuah K, Ahmed G. Laboratory evaluation of hepatitis C virus infection in patients undergoing hemodialysis from North East India. J Clin Exp Hepatol. 2022, 12:475-82. 10.1016\/j.jceh.2021.05.011","journal-title":"J Clin Exp Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4103\/1319-2442.160219","article-title":"Prevalence of hepatitis C and B virus infections among hemodialysis patients in Karaj, Iran","volume":"26","author":"Tajbakhsh R","year":"2015","unstructured":"Tajbakhsh R. Prevalence of hepatitis C and B virus infections among hemodialysis patients in Karaj, Iran. Saudi J Kidney Dis Transpl. 2015, 26:792-6. 10.4103\/1319-2442.160219","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.11648\/j.cmr.20170602.11","article-title":"Hepatitis C virus seroconversion among hemodialysis patients and the role of hepatitis C virus positive patient's isolation in Benha, Egypt","volume":"6","author":"Ibrahim ME","year":"2017","unstructured":"Ibrahim ME, Elawady MA. Hepatitis C virus seroconversion among hemodialysis patients and the role of hepatitis C virus positive patient's isolation in Benha, Egypt. Clin Med Res. 2017, 6:31-6. 10.11648\/j.cmr.20170602.11","journal-title":"Clin Med Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2007.02.007","article-title":"Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran","volume":"18","author":"Zamani S","year":"2007","unstructured":"Zamani S, Ichikawa S, Nassirimanesh B, et al.. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran. Int J Drug Policy. 2007, 18:359-63. 10.1016\/j.drugpo.2007.02.007","journal-title":"Int J Drug Policy"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-8-438","article-title":"Rising burden of hepatitis C virus in hemodialysis patients","volume":"8","author":"Khan S","year":"2011","unstructured":"Khan S, Attaullah S, Ali I, et al.. Rising burden of hepatitis C virus in hemodialysis patients. Virol J. 2011, 8:438. 10.1186\/1743-422X-8-438","journal-title":"Virol J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/12.4.736","article-title":"Incidence and risk factors of hepatitis C virus infection in a haemodialysis unit","volume":"12","author":"Forns X","year":"1997","unstructured":"Forns X, Fern\u00e1ndez-Llama P, Pons M, et al.. Incidence and risk factors of hepatitis C virus infection in a haemodialysis unit. Nephrol Dial Transplant. 1997, 12:736-40. 10.1093\/ndt\/12.4.736","journal-title":"Nephrol Dial Transplant"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmhg.2015.05.003","article-title":"An overview on hepatitis C virus genotypes and its control","volume":"16","author":"Nouroz F","year":"2015","unstructured":"Nouroz F, Shaheen S, Mujtaba G, Noreen S. An overview on hepatitis C virus genotypes and its control. Egypt J Med Hum Genet. 2015, 16:291-8. 10.1016\/j.ejmhg.2015.05.003","journal-title":"Egypt J Med Hum Genet"},{"key":"ref28","article-title":"Hepatitis C in hemodialysis patients\u2019 needs more attention for control and review the risk factors","volume":"21","author":"Alavian SM","year":"2010","unstructured":"Alavian SM. Hepatitis C in hemodialysis patients\u2019 needs more attention for control and review the risk factors. Saudi J Kidney Dis Transpl. 2010, 21:357-8.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref29","article-title":"Prevention of hepatitis C virus in hemodialysis patients: five years experience from a single center","volume":"21","author":"Mohamed WZ","year":"2010","unstructured":"Mohamed WZ. Prevention of hepatitis C virus in hemodialysis patients: five years experience from a single center. Saudi J Kidney Dis Transpl. 2010, 21:548-54.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1590\/s0100-879x2006000500005","article-title":"Prevalence of hepatitis C virus (HCV) infection and HCV genotypes of hemodialysis patients in Salvador, Northeastern Brazil","volume":"39","author":"Silva LK","year":"2006","unstructured":"Silva LK, Silva MB, Rodart IF, et al.. Prevalence of hepatitis C virus (HCV) infection and HCV genotypes of hemodialysis patients in Salvador, Northeastern Brazil. Braz J Med Biol Res. 2006, 39:595-602. 10.1590\/s0100-879x2006000500005","journal-title":"Braz J Med Biol Res"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.17417","article-title":"Risk factors of HCV seroconversion in hemodialysis patients in Tabriz, Iran","volume":"14","author":"Somi MH","year":"2014","unstructured":"Somi MH, Etemadi J, Ghojazadeh M, Farhang S, Faramarzi M, Foroutan S, Soleimanpour M. Risk factors of HCV seroconversion in hemodialysis patients in Tabriz, Iran. Hepat Mon. 2014, 14:e17417. 10.5812\/hepatmon.17417","journal-title":"Hepat Mon"},{"key":"ref32","article-title":"Seroconversion rate of hepatitis C virus infection among hemodialysis patients in Al-Kadhimiya Teaching Hospital (dialysis unit)","volume":"9","author":"Al-Rubaie HM","year":"2011","unstructured":"Al-Rubaie HM, Malik AS. Seroconversion rate of hepatitis C virus infection among hemodialysis patients in Al-Kadhimiya Teaching Hospital (dialysis unit). Iraqi J Med Sci. 2011, 9:343-9.","journal-title":"Iraqi J Med Sci"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31060","article-title":"Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America recommendations for testing, managing, and treating hepatitis C virus infection","volume":"71","author":"Ghany MG","year":"2020","unstructured":"Ghany MG, Morgan TR. Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America recommendations for testing, managing, and treating hepatitis C virus infection. Hepatology. 2020, 71:686-721. 10.1002\/hep.31060","journal-title":"Hepatology"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3367-3","article-title":"Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort","volume":"18","author":"Adland E","year":"2018","unstructured":"Adland E, Jesuthasan G, Downs L, et al.. Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort. BMC Infect Dis. 2018, 18:461. 10.1186\/s12879-018-3367-3","journal-title":"BMC Infect Dis"},{"key":"ref35","article-title":"Seroprevalence of anti-HCV antibodies among blood donors of North India","volume":"138","author":"Makroo RN","year":"2013","unstructured":"Makroo RN, Walia RS, Chowdhry M, Bhatia A, Hegde V, Rosamma NL. Seroprevalence of anti-HCV antibodies among blood donors of North India. Indian J Med Res. 2013, 138:125-8.","journal-title":"Indian J Med Res"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1023\/a:1024887211146","article-title":"The prevalence of hepatitis C virus antibodies among the voluntary blood donors of New Delhi, India","volume":"18","author":"Jain A","year":"2003","unstructured":"Jain A, Rana SS, Chakravarty P, et al.. The prevalence of hepatitis C virus antibodies among the voluntary blood donors of New Delhi, India. Eur J Epidemiol. 2003, 18:695-8. 10.1023\/a:1024887211146","journal-title":"Eur J Epidemiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.5281\/hsd.v14i1.74","article-title":"Incidence and potential risk factors for seroconversion to hepatitis C positivity in patients on maintenance hemodialysis in Sub-Saharan Africa: a single center study","volume":"14","author":"Ashuntantang GE","year":"2013","unstructured":"Ashuntantang GE, Njouom R, Kengne AP, Ngemhe AN, Kaze FF, Luma HN, Njoya O. Incidence and potential risk factors for seroconversion to hepatitis C positivity in patients on maintenance hemodialysis in Sub-Saharan Africa: a single center study. Health Sci Dis. 2013, 14:10-5. 10.5281\/hsd.v14i1.74","journal-title":"Health Sci Dis"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2009.04.001","article-title":"Prevalence and geographic distribution of hepatitis C virus genotypes in Indian patient cohort","volume":"9","author":"Narahari S","year":"2009","unstructured":"Narahari S, Juwle A, Basak S, Saranath D. Prevalence and geographic distribution of hepatitis C virus genotypes in Indian patient cohort. Infect Genet Evol. 2009, 9:643-5. 10.1016\/j.meegid.2009.04.001","journal-title":"Infect Genet Evol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.4103\/0255-0857.118875","article-title":"Genotypes of hepatitis C virus in the Indian sub-continent: a decade-long experience from a tertiary care hospital in South India","volume":"31","author":"Christdas J","year":"2013","unstructured":"Christdas J, Sivakumar J, David J, Daniel HD, Raghuraman S, Abraham P. Genotypes of hepatitis C virus in the Indian sub-continent: a decade-long experience from a tertiary care hospital in South India. Indian J Med Microbiol. 2013, 31:349-53. 10.4103\/0255-0857.118875","journal-title":"Indian J Med Microbiol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad319","article-title":"Hepatitis C guidance 2023 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection","author":"Bhattacharya D","year":"2023","unstructured":"Bhattacharya D, Aronsohn A, Price J, Lo Re V. Hepatitis C guidance 2023 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection. Clin Infect Dis. 2023, 1-18. 10.1093\/cid\/ciad319","journal-title":"Clin Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/284517-hepatitis-c-virus-seroprevalence-and-genotypic-distribution-among-hemodialysis-patients-at-a-teaching-and-training-hospital-in-western-rajasthan-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T08:55:34Z","timestamp":1724057734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/284517-hepatitis-c-virus-seroprevalence-and-genotypic-distribution-among-hemodialysis-patients-at-a-teaching-and-training-hospital-in-western-rajasthan-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,19]]},"references-count":40,"URL":"https:\/\/doi.org\/10.7759\/cureus.67175","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,19]]}}}